Valion Bio, Inc. SEC filings VBIO

Valion Bio, Inc. has 402 filings in SEC EDGAR's recent list, going back to Sep 10, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.

Valion Bio, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Sep 24, 2026 Sep 22, 2026
4 Insider transaction Sep 24, 2026 Sep 18, 2026
3 Initial insider ownership Sep 17, 2026 Aug 27, 2026
3 Initial insider ownership Sep 17, 2026 Aug 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 4, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 3, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 2, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 27, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 24, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 19, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 11, 2026 —
SCHEDULE 13D Ownership over 5% (active) Aug 3, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2026 —
4 Insider transaction Jun 18, 2026 Jun 18, 2026
4 Insider transaction May 20, 2026 May 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
4 Insider transaction May 4, 2026 May 1, 2026
3 Initial insider ownership May 4, 2026 May 1, 2026
4 Insider transaction Apr 20, 2026 Apr 15, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Mar 19, 2026 Mar 18, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 27, 2026 —
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Dec 22, 2025 Dec 18, 2025
4 Insider transaction Dec 22, 2025 Dec 18, 2025
4 Insider transaction Sep 24, 2025 Sep 22, 2025
4/A Filing Aug 22, 2025 Aug 6, 2025
4/A Filing Aug 22, 2025 Aug 6, 2025
4/A Filing Aug 22, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
3 Initial insider ownership Feb 24, 2025 Feb 18, 2025
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Oct 3, 2024 Sep 30, 2024
4 Insider transaction Oct 3, 2024 Oct 1, 2024
3 Initial insider ownership Oct 3, 2024 Oct 1, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
3 Initial insider ownership Jul 9, 2024 Jul 1, 2024
SC 13G Ownership over 5% (passive) May 15, 2024 —
4 Insider transaction Mar 22, 2024 Mar 12, 2024
4 Insider transaction Mar 22, 2024 Mar 12, 2024
4 Insider transaction Mar 22, 2024 Mar 12, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 24, 2023 —
SC 13G Ownership over 5% (passive) Jul 17, 2023 —
4 Insider transaction Jun 16, 2023 Jun 14, 2023
4 Insider transaction Jun 16, 2023 Jun 14, 2023
4 Insider transaction Jun 16, 2023 Jun 14, 2023
3 Initial insider ownership May 10, 2023 Apr 28, 2023
4 Insider transaction May 10, 2023 May 8, 2023
4 Insider transaction May 10, 2023 May 8, 2023
4 Insider transaction May 10, 2023 May 8, 2023
SC 13G Ownership over 5% (passive) Feb 21, 2023 —
5 Annual insider ownership Feb 14, 2023 Dec 31, 2022
4/A Ownership document Jun 21, 2022 Jun 14, 2022
4/A Ownership document Jun 21, 2022 Jun 14, 2022
4/A Ownership document Jun 21, 2022 Jun 14, 2022
4 Insider transaction Jun 16, 2022 Jun 14, 2022
4 Insider transaction Jun 16, 2022 Jun 14, 2022
4 Insider transaction Jun 16, 2022 Jun 14, 2022
4 Insider transaction Apr 5, 2022 Apr 1, 2022
3 Initial insider ownership Apr 5, 2022 Apr 1, 2022
SC 13G Ownership over 5% (passive) Feb 14, 2022 —
SC 13G Ownership over 5% (passive) Feb 14, 2022 —
4 Insider transaction Feb 8, 2022 Feb 4, 2022
4 Insider transaction Feb 8, 2022 Feb 4, 2022
4 Insider transaction Feb 8, 2022 Feb 4, 2022
4 Insider transaction Dec 16, 2021 Dec 14, 2021
4 Insider transaction Dec 16, 2021 Dec 14, 2021
4 Insider transaction Dec 16, 2021 Dec 14, 2021
4 Insider transaction Dec 16, 2021 Dec 14, 2021
4 Insider transaction Dec 16, 2021 Dec 14, 2021
3 Initial insider ownership Nov 17, 2021 Nov 10, 2021
4 Insider transaction Nov 15, 2021 Nov 12, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021
3 Initial insider ownership Nov 10, 2021 Nov 10, 2021

Showing 96 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Antonio, TX
SEC filer status
, Emerging growth company
SEC CIK
1787740
Former names
Tivic Health Systems, Inc. (until Apr 23, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.